PL3566713T3 - Wstrzykiwalne biomateriały - Google Patents

Wstrzykiwalne biomateriały

Info

Publication number
PL3566713T3
PL3566713T3 PL19182834T PL19182834T PL3566713T3 PL 3566713 T3 PL3566713 T3 PL 3566713T3 PL 19182834 T PL19182834 T PL 19182834T PL 19182834 T PL19182834 T PL 19182834T PL 3566713 T3 PL3566713 T3 PL 3566713T3
Authority
PL
Poland
Prior art keywords
injectable biomaterials
biomaterials
injectable
Prior art date
Application number
PL19182834T
Other languages
English (en)
Inventor
Anthony Steven Weiss
Suzanne Marie Mithieux
Original Assignee
Allergan Pharmaceuticals International Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009901028A external-priority patent/AU2009901028A0/en
Application filed by Allergan Pharmaceuticals International Limited filed Critical Allergan Pharmaceuticals International Limited
Publication of PL3566713T3 publication Critical patent/PL3566713T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL19182834T 2009-03-10 2010-03-10 Wstrzykiwalne biomateriały PL3566713T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2009901028A AU2009901028A0 (en) 2009-03-10 Injectable biomaterials
PCT/AU2010/000275 WO2010102337A1 (en) 2009-03-10 2010-03-10 Injectable biomaterials
EP19182834.2A EP3566713B1 (en) 2009-03-10 2010-03-10 Injectable biomaterials
EP10750240.3A EP2405936B1 (en) 2009-03-10 2010-03-10 Injectable biomaterials

Publications (1)

Publication Number Publication Date
PL3566713T3 true PL3566713T3 (pl) 2021-12-06

Family

ID=42727703

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19182834T PL3566713T3 (pl) 2009-03-10 2010-03-10 Wstrzykiwalne biomateriały

Country Status (13)

Country Link
US (1) US8974803B2 (pl)
EP (4) EP2405936B1 (pl)
JP (1) JP5684154B2 (pl)
KR (1) KR101708622B1 (pl)
CN (1) CN102348464B (pl)
AU (1) AU2010223851B2 (pl)
BR (1) BRPI1009422B1 (pl)
CA (1) CA2787849C (pl)
DK (2) DK3566713T3 (pl)
ES (3) ES2755902T3 (pl)
HU (2) HUE053947T2 (pl)
PL (1) PL3566713T3 (pl)
WO (1) WO2010102337A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0365746A (ja) * 1989-08-04 1991-03-20 Nec Corp 入出力制御装置
JP5684154B2 (ja) 2009-03-10 2015-03-11 ザ・ユニバーシティ・オブ・シドニー 注射用生体材料
JP2012532963A (ja) * 2009-07-10 2012-12-20 ダウ グローバル テクノロジーズ エルエルシー 電気用積層板組成物における使用のためのコア／シェルゴム
BR112014007451A2 (pt) * 2011-09-30 2017-04-04 Univ Sydney síntese in vivo de fibras elásticas
WO2014063194A1 (en) 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel
ES2860023T3 (es) 2012-12-10 2021-10-04 Allergan Pharmaceuticals Int Ltd Fabricación de constructos elásticos tridimensionales escalables
KR20230004965A (ko) * 2013-08-13 2023-01-06 앨러간 파마슈티컬스 인터내셔널 리미티드 손상 조직의 재생
ITMI20131927A1 (it) 2013-11-20 2015-05-21 Cosmo Technologies Ltd Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection. emulsioni o microemulsioni per uso nella resezione mucosale endoscopica e/o dissezione submucosale endoscopica
DE102015207843B4 (de) 2015-04-28 2018-06-07 Duesenfeld Gmbh Verfahren zum Behandeln gebrauchter Batterien und Batterie-Verarbeitungsanlage
CA2996427A1 (en) 2015-09-01 2017-03-09 Allergan Pharmaceuticals International Limited Formation of bone
US10899667B2 (en) * 2017-05-26 2021-01-26 Clemson University Covalently cross-linked lignocellulosic composites and applications thereof
CN107376024B (zh) * 2017-06-29 2021-03-16 成都清科生物科技有限公司 一种用于治疗女性压力性尿失禁的注射制剂及注射方法
MX2022002275A (es) * 2019-08-23 2022-06-02 Allergan Pharmaceuticals Int Ltd Tropoelastina para uso en el tratamiento de cicatrices de acne.
BR112022023209A2 (pt) * 2020-05-14 2023-02-07 Allergan Pharmaceuticals Int Ltd Composições compreendendo tropoelastina reticulada ao ácido hialurônico e métodos de uso das mesmas
WO2023178219A1 (en) * 2022-03-16 2023-09-21 Fibrobiologics, Inc. Therapeutic use of fibroblasts for use in wound healing

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU688746B2 (en) 1992-12-22 1998-03-19 University Of Sydney, The Synthetic polynucleotides
US5726040A (en) 1993-11-10 1998-03-10 Ensley; Burt D. Cosmetic compositions including tropoelastin isomorphs
US7001328B1 (en) 1994-11-15 2006-02-21 Kenton W. Gregory Method for using tropoelastin and for producing tropoelastin biomaterials
US6489446B1 (en) 1996-08-07 2002-12-03 Hsc Research And Development Limited Partnership Self-aligning peptides modeled on human elastin and other fibrous proteins
JP2001505539A (ja) 1996-08-07 2001-04-24 プロテイン・スペシャルティーズ，リミテッド エラスチン及び他の線維状タンパク質由来の自己整列ペプチド
AUPO811797A0 (en) 1997-07-18 1997-08-14 University Of Sydney, The Tropoelastin derivatives
AU9313298A (en) 1997-09-04 1999-03-22 Point Biomedical Corporation Injectable tissue reconstruction material
AUPP472398A0 (en) 1998-07-17 1998-08-13 University Of Sydney, The Protease susceptibility II
US7193043B1 (en) 1998-07-17 2007-03-20 Weiss Anthony S Tropoelastin derivatives
CA2383539C (en) 1999-05-28 2007-12-04 Kenton W. Gregory Methods for producing laminated elastin, elastin-based materials and tropoelastin products for repairing and/or replacing tissue
DK1229940T3 (da) 1999-11-15 2014-08-18 Piramal Healthcare Canada Ltd Temperaturstyret og ph-afhængig selvgelerende, vandig biopolymeropløsning
US20050244393A1 (en) * 1999-12-22 2005-11-03 Henogen S.A. Sealant or tissue generating product
US6808707B2 (en) 2000-02-04 2004-10-26 Matrix Design Wound healing compositions and methods using tropoelastin and lysyl oxidase
US7125960B2 (en) 2001-05-30 2006-10-24 Chisso Corporation Crosslinked elastin and process for producing the same
US8038991B1 (en) 2003-04-15 2011-10-18 Abbott Cardiovascular Systems Inc. High-viscosity hyaluronic acid compositions to treat myocardial conditions
US8383158B2 (en) 2003-04-15 2013-02-26 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US8226715B2 (en) * 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
US7968085B2 (en) 2004-07-05 2011-06-28 Ascendis Pharma A/S Hydrogel formulations
US8828433B2 (en) 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
EP1945144A4 (en) 2005-10-19 2012-12-05 Kenton W Gregory PROCESS FOR THE USE AND PRODUCTION OF TROPOELASTIN AND BIOMATERIALS BASED ON TROPOELASTIN
US20070237735A1 (en) * 2006-03-31 2007-10-11 Laboratoires Dermo-Cosmetik Inc. Anti-aging composition, kit and method of use
EP2117620A4 (en) 2006-09-29 2010-12-01 Martin Kean Chong Ng PROTOELASTINE BIOMATERIALS FROM TROOELASTINE
WO2008058323A1 (en) 2006-11-13 2008-05-22 The University Of Sydney Use of tropoelastin for repair or restoration of tissue
US8469961B2 (en) * 2008-03-05 2013-06-25 Neville Alleyne Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints
US8940331B2 (en) 2008-11-22 2015-01-27 The Board Of Trustees Of The Leland Stanford Junior University Hydrogels, methods of making hydrogels, methods of using hydrogels, and methods of isolating, trapping, attracting, and/or killing cancer cells
JP5684154B2 (ja) 2009-03-10 2015-03-11 ザ・ユニバーシティ・オブ・シドニー 注射用生体材料
US8658711B2 (en) 2010-09-29 2014-02-25 Rutgers, The State University Of New Jersey Process for the synthesis of methacrylate-derivatized type-1 collagen and derivatives thereof

Also Published As

Publication number Publication date
AU2010223851B2 (en) 2017-03-16
EP2405936A4 (en) 2012-12-19
HUE047235T2 (hu) 2020-04-28
BRPI1009422A2 (pt) 2016-03-01
HUE053947T2 (hu) 2021-08-30
EP2405936B1 (en) 2019-08-21
US8974803B2 (en) 2015-03-10
KR20110127746A (ko) 2011-11-25
CA2787849C (en) 2018-03-06
ES3010268T3 (en) 2025-04-01
DK3566713T3 (da) 2021-04-06
JP5684154B2 (ja) 2015-03-11
EP3881825B1 (en) 2024-12-25
EP3881825A1 (en) 2021-09-22
WO2010102337A1 (en) 2010-09-16
ES2871977T3 (es) 2021-11-02
EP2405936A1 (en) 2012-01-18
ES2755902T3 (es) 2020-04-24
JP2012519713A (ja) 2012-08-30
US20120003283A1 (en) 2012-01-05
EP4534115A2 (en) 2025-04-09
DK2405936T3 (da) 2019-11-04
CA2787849A1 (en) 2010-09-16
EP3566713B1 (en) 2021-03-03
EP3566713A1 (en) 2019-11-13
CN102348464A (zh) 2012-02-08
EP4534115A3 (en) 2025-06-11
BRPI1009422B1 (pt) 2019-10-01
AU2010223851A1 (en) 2011-09-22
KR101708622B1 (ko) 2017-02-21
CN102348464B (zh) 2016-05-25

Similar Documents

Publication Publication Date Title
HUE047235T2 (hu) Befecskendezhetõ biológiai anyagok
GB201002407D0 (en) Electic machine - flux
IL219073A0 (en) Combination
GB0900269D0 (en) Silicate-substituted hydroxyapatite
GB2476400B (en) Syringes
IL219103A0 (en) Combination
IL219786A0 (en) Combination
IL218999A0 (en) Combination
IL218797A0 (en) Combination
IL219000A0 (en) Combination
IL218846A0 (en) Combination
IL218801A0 (en) Combination
AU2009901028A0 (en) Injectable biomaterials
GB0820320D0 (en) Biomaterials
GB201014136D0 (en) Biomaterial
IL199679A0 (en) Injectable pharmaceutical composition
GB0906555D0 (en) Tolerance
GB0921939D0 (en) Syringes
AU327918S (en) Oven
GB0913322D0 (en) Xxxx
GB0906696D0 (en) Combination
GB0901391D0 (en) Combination